EMR - Why You Should Buy This Undervalued Stock Before Everyone Else Does
Emerson Electric (NYSE: EMR) may have an interesting mix of businesses. But that didn't deter the automation, climate technology, and tools company from crushing its original guidance when it reported its fiscal 2021 (ending Sept. 30) earnings. In addition, Emerson started fiscal 2022 with its three-month trailing orders up 16%, and management guided toward a 19% increase in earnings for 2022.
However, the stock only rose 16% in 2021, significantly underperforming the S&P 500 's 27% gain. It's an underperformance that I don't think will repeat in 2022.
Image source: Getty Images.
For further details see:
Why You Should Buy This Undervalued Stock Before Everyone Else Does